Trademark: 97622447
Word
SYANTRA DX
Status Date
Monday, January 22, 2024
Filing Date
Thursday, October 6, 2022
5 Pharmaceutical preparations for the treatment of cancer
1 Diagnostic kits comprised of biological assays for use in fields of biological research and diagnostic testing for breast cancer, colon cancer and lung cancer; assay plates for use in experimental biology research for the purpose of assessment of cell health after experimental treatment or manipulation
42 Laboratory research in the field of cancer screening and treatment
The mark consists of The mark consists of the stylized "SYANTRA DX" with the word "SYANTRA" in light blue, and the letter "D" in "DX" in blue, and the letter "X" in "DX" in blue and light blue.
The color(s) blue and light blue is/are claimed as a feature of the mark.
"DX"
Jan 22, 2024
Report Completed Suspension Check Case Still Suspended
Jul 25, 2023
Notification Of Letter Of Suspension E-Mailed
Jul 25, 2023
Letter Of Suspension E-Mailed
Jul 25, 2023
Suspension Letter Written
Jul 25, 2023
Teas/Email Correspondence Entered
Jul 24, 2023
Correspondence Received In Law Office
Jul 24, 2023
Teas Response To Office Action Received
Jul 20, 2023
Notification Of Non-Final Action E-Mailed
Jul 20, 2023
Non-Final Action E-Mailed
Jul 20, 2023
Non-Final Action Written
Jul 20, 2023
Assigned To Examiner
Oct 23, 2022
New Application Office Supplied Data Entered
Oct 10, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
